Health Care & Life Sciences » Pharmaceuticals | Hisamitsu Pharmaceutical Co. Inc.

Hisamitsu Pharmaceutical Co. Inc.

Hisamitsu Pharmaceutical Co. Inc.
Stock Exchange Tokyo Stock Exchange
EPS
JPY229.85
Market Cap
JPY370.34 B
Shares Outstanding
95.16 M
Public Float
37.87 M

Profile

Address
408 Tashiro Daikan-machi
Tosu Saga 841
Japan
Employees -
Website http://www.hisamitsu.co.jp
Updated 07/08/2019
Hisamitsu Pharmaceutical Co., Inc. engages in the research, development, manufacture, and sale of pharmaceuticals and related products. Its products are sold under Salonpas, Salonsip, Mohrus, ByeBye-Fever, Lifecella, and Keplat brands. It also provides ethical pharmaceuticals, over the counter drugs, medical devices, health supplements, and topical analgesic products.

Financials

View All

Hirotaka Nakatomi
Chairman & Chief Executive Officer
Kazuhide Nakatomi
President, COO & Representative Director